key: cord-0850280-gu4uipl3
authors: Brehm, T. T.; Schwinge, D.; Lampalzer, S.; Schlicker, V.; Kuechen, J.; Thompson, M.; Ullrich, F.; Huber, S.; Schmiedel, S.; Addo, M. M.; Luetgehetmann, M.; Knobloch, J. K.; Schulze zur Wiesch, J.; Lohse, A. W.
title: High effectiveness of multimodal infection control interventions in preventing SARS-CoV-2 infections in healthcare professionals: a prospective longitudinal seroconversion study
date: 2020-07-31
journal: nan
DOI: 10.1101/2020.07.31.20165936
sha: 3bcb3578608e0a7aece0cc10c729b304bb01c0b9
doc_id: 850280
cord_uid: gu4uipl3

Objective: To assess the effectiveness of multimodal infection control interventions in the prevention of SARS-CoV-2 infections in healthcare professionals Design: Sequential follow-up study Setting: Largest tertiary care centre in northern Germany Participants: 1253 employees of the University Medical Center Hamburg-Eppendorf were sequentially assessed for the presence of SARS-CoV-2 IgG antibodies at the beginning of the covid-19 epidemic (20 March - 9 April), one month (20 April - 8 May), and another two months later (22 June - 24 July). Of those, 1026 were healthcare workers (HCWs) of whom 292 were directly involved in the care of covid-19 patients. During the study period, infection control interventions were deployed, those included i) strict barrier nursing of all known covid-19 patients including FFP2 (N95) masks, goggles, gloves, hoods and protective gowns, ii) visitor restrictions with access control at all hospital entries, iii) mandatory wearing of disposable face masks in all clinical settings, and iv) universal RT-PCR admission screening of patients. Main Outcome Measures: SARS-CoV-2 IgG seroconversion rate Results: At the initial screening, ten participants displayed significant IgG antibody ratios. Another ten individuals showed seroconversion at the second time point one month later, only two further participants seroconverted during the subsequent two months. The overall SARS-CoV-2 seroprevalence in the study cohort at the last follow-up was 1.8%, the seroconversion rate dropped from 0.81% to 0.08% per month despite a longer observation period. Amongst HCWs seropositivity was increased in those directly involved in the care of patients with SARS-CoV-2 infections (3.8%, n=11) compared to other HCWs (1.4%, n=10, P=0.025). However, after the adoption of all multimodal infection control interventions seroconversions were observed in only two more HCWs, neither of whom were involved in inpatient care. Conclusion: Multimodal infection control and prevention interventions are highly effective in mitigating SARS-CoV-2 infections of healthcare professionals.

CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2020. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2020. . https://doi.org/10.1101/2020.07.31.20165936 doi: medRxiv preprint

Healthcare workers (HCWs) are at the front line of the coronavirus disease 2019 (covid-19) 97 pandemic response and disproportionally at risk of contracting severe acute respiratory 98 syndrome coronavirus 2 (SARS-CoV-2) due to occupational exposure. 1 2 The Chinese 99 ophthalmologist Li Wenliang, who was one of the first physicians to issue emergency warnings 100 about a novel viral pneumonia that was later identified as covid-19 died after being infected 101 when caring for a pre-symptomatic patient. 3 This individual case as well as larger case series 102 illustrate the considerable challenges of HCW protection, especially since the risk of infections 103 from pre-or asymptomatic SARS-CoV-2 infected individuals was initially often 104 underestimated. 4 5 Protection of HCWs from infection requires not only strict application of 105 personal protective equipment (PPE), but also the prompt identification of infected 106 individuals, who may be asymptomatic or oligosymptomatic. Protection of HCWs not only 107 serves as personal protection but is also paramount to mitigate nosocomial transmission to 108 vulnerable patients and fellow HCWs. HCW infections may also lead to critical staff shortages. 109

various efficacies, including the use of adequate PPE 6-8 , universal admission screening of 111 patients 9 10 , and RT-PCR surveillance of exposed HCWs. 11 12 However, reports about limited 112 availability of sufficient PPE and high infection rates in HCWs, particularly during the early 113 phase of the outbreak, have raised concerns about whether HCWs can be adequately 114 protected from contracting occupational infections. 13 CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 31, 2020. . https://doi.org/10.1101/2020.07.31.20165936 doi: medRxiv preprint

Participants were recruited in the screening period 1 (SP 1) between 20 March and 9 April 130 2020 by informing employees of the University Medical Center Hamburg-Eppendorf. The city-131 state of Hamburg with 1.8 million inhabitants and a metropolitan catchment area of more 132 than 4.5 million inhabitants was affected by the pandemic relatively early due to public 133 holidays in March 2020, when numerous travelers returned from high-risk regions, especially 134

Italian and Austrian ski resorts. By 24 July, a total of 5291 cases had been confirmed, which 135 constitutes one of the highest rates in Germany. 16 The University Medical Center Eppendorf, which has 1738 hospital beds, has treated more than 170 covid-19 patients during 137 the study period. Of those, 70 were admitted to the intensive care unit, 51 required 138 mechanical ventilation, and 12 patients required extracorporeal membrane oxygenation 139 (ECMO) therapy. Of note, a large number of immunocompromised patients with high viral 140 loads and a protracted course of disease posed a particularly high transmission risk to HCWs. 17 141

Participants were recruited to the study via an internal email newsletter. To assess the 142 infection rate of employees, we assessed seroconversion at one and three months: i) sampling 143 period 2 (SP 2) one month after SP 1 (20 April to 8 May 2020) and ii) sampling period 3 (SP 3) 144 another 2 months after SP 2 (22 June to 24 July). 145 146

On the day of recruitment, we collected demographic and general work-related data including 148 profession, occupational area, and patient contacts using a questionnaire. In addition, we 149 used another questionnaire to assess known and possible past contact to covid-19 patients 150 with or without sufficient PPE as well as presence of symptoms during the past 4 weeks at SP 151 1 and SP 2 and during the past 8 weeks at SP 3 respectively. Fever, cough, and dyspnea were 152 classified as typical symptoms while rhinorrhea, sore throat, headache, stomach pain, joint 153 and muscle pain, nausea, and diarrhea and were considered as uncharacteristic symptoms. 154

Questionnaires were available both paper-based and via online REDcap electronic data 155 capture tools hosted at our institution. 18 19 Study participants with positive SARS-CoV-2 IgG 156 ratio were contacted again by phone to ask if nasopharyngeal swabs for RT-PCR had been 157 performed and whether a source of infection could be identified. 158 159 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 31, 2020. supply was scarce throughout the first two months, application of strict protocols to limit 174 wasteful use of equipment allowed sufficient supply all through the pandemic. When first 175 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 31, 2020. roll-out period of about ten days until full adherence across all hospital departments. In 181 addition, RT-PCR testing of staff at risk was offered as of May 11, but this measure was 182 primarily instituted as a reassurance measure for our staff rather than an infection control 183 measure. 184 185

During all three sampling periods, serum samples were drawn from the study participants. A 187 semi-quantitative SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) targeting the 188 S1-Domain of the S-protein spike protein subunit was performed using a commercial kit 189 However, an optimized IgG ratio of ≥ 1.5, has been shown to display a specificity of 100% by 194 us and by others. 21 Therefore, we used both the manufacturer's and this more stringent cut-195 off value for positive results to account for optimal specificity in a low prevalence 196 environment. Given the sequential testing in our study population and the expected rise of 197

IgG antibody ratio ≥1.5 at some time point in infected individuals, this cut-off value is 198 considered the best compromise for optimum sensitivity and specificity. Study participants 199

were classified as seropositive in all future sampling periods, if they had an IgG antibody ratio 200 ≥1.5 at least once, even if antibody ratios waned over time. This was found to be the case in 201 three study participants, who became seronegative at SP 3. However, in order to also look at 202 the data with maximum sensitivity, we also analyzed the participants with a ratio of >1.1. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2020. . https://doi.org/10.1101/2020.07.31.20165936 doi: medRxiv preprint

Results were subjected to statistical analysis using SPSS 20.0 (IBM, Armonk, NY, USA). Fishers' 209 exact test was used to the determine association between two categorical variables. A two-210 sided P value less than 0.05 was considered significant. 211 212

The study was presented to and approved by the academic and non-academic workers 214 representation boards of our hospital and the design agreed with both boards as well as the 215 management board of the hospital. 216 217

A total of 1253 individuals were included during SP 1, which represent around 11% of all 220 employees at our centre (table 2) . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2020. . https://doi.org/10.1101/2020.07.31.20165936 doi: medRxiv preprint All study participants participated at the second follow up visit, but 23 (1.8%) missed the first 243

follow-up visit. The average age of the study cohort was 38.4 years; 934 were women and 308 244 were men. The majority of participants (n=1026, 81.9%) were HCWs such as nurses (n=444, 245 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2020. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2020. . https://doi.org/10.1101/2020.07.31.20165936 doi: medRxiv preprint

Out of all clearly seropositive study participants, a total of 40.9% (n=9), one of them before 294 SP 1 and the others between SP 1 and SP 2, had been diagnosed with covid-19 by RT-PCR and 295 thus had been placed under quarantine during the study period. Another six seropositive 296

HCWs reported that they had at least one nasopharyngeal swab performed due to symptoms 297 or close contact with a covid-19 case but were tested negative at that time. The remainder of 298 seven clearly seropositive individuals had not been tested by RT-PCR at all. 299 300

Complete information on symptoms throughout the study period was provided by 1061 302 This study demonstrates a very low overall SARS-CoV-2 seroprevalence in hospital workers at 323 our tertiary care centre, and the increasing effectiveness of a combination of infection control 324 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2020. States of America (7,6 -36%) 29 30 . Those high infection rates are likely to be at least partially 344 attributable to insufficient protection of exposed HCWs. While the effectiveness of universal 345 use of face masks at hospitals has been shown to significantly decrease hospital transmission 346 6 7 , shortages of appropriate PPE for HCWs in many hospitals have emerged particularly during 347 the early phase of the pandemic. However, adequate PPE when caring for confirmed covid- fact that three HCWs seroconverted during the study period despite reporting use of 355 appropriate PPE when caring for covid-19 patients underlines that PPE alone is not sufficient 356 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2020. . https://doi.org/10.1101/2020.07.31.20165936 doi: medRxiv preprint 14 to prevent viral transmission to HCWs. To our surprise, the majority of seropositive study 357 participants had not been diagnosed with SARS-CoV-2 infections despite a very low threshold 358 in our hospital for RT-PCR screening, with more than 7.300 nasopharyngeal swab 359 examinations of hospital HCWs performed during the study period. Furthermore, symptoms 360 compatible with covid-19 were widely prevalent in healthcare professionals regardless of 361 serological results, a number of seropositive employees did not report any such symptoms 362 and were thus not tested. This demonstrates that symptom-based testing of HCWs, while an 363 important tool to mitigate nosocomial infections, has limited sensitivity and very low 364 specificity in detecting infected HCWs. Complete protection of HCWs is not only helpful for 365 their direct protection but is also key for preventing nosocomial infections in patients. 366 367

There are some limitations to our study: firstly, we did not recruit a strictly representative 369 sample of healthcare professionals at our institution, since participation was voluntary. 370

However, the distribution of professions was close to the overall hospital workforce 371 distribution. We included a somewhat higher proportion of clinically exposed HCWs, in 372 particular front-line HCWs from the emergency department, intensive care and infectious 373 diseases departments, most likely because these HCWs were highly exposed and thus more 374 motivated to participate in the study. Secondly, since several multimodal infection control 375 interventions were sequentially adopted and the study did not include a control group, this 376 study is not able to answer the question which measures are most effective in preventing 377 healthcare transmission, and which might have been superfluous. Thirdly, sensitivity and 378 specificity of serological assays is limited, so a precise assessment of the number of infected 379

HCWs is not possible. However, the results were independent of the cut-off levels used for 380 serological testing (figure 2), supporting the reliability of the results. The guarantors affirm that this manuscript is an honest, accurate, and transparent account of 405 the study being reported; that no important aspects of the study have been omitted; and that 406 any discrepancies from the study as planned (and, if relevant, registered) have been 407 explained. 408 409

The authors received no external funding for this work. 411 412

All authors have completed the ICMJE uniform disclosure form at 414 www.icmje.org/coi_disclosure.pdf and declare: AWL had a material transfer agreement with 415

Euroimmun GmbH, which included ten ELISA plates as well as technical help provided by the 416 company when setting up the newly established ELISA. All other authors declare no support 417 from any organisation for the submitted work. All authors declare no financial relationships 418 with any organisations that might have an interest in the submitted work in the previous three 419 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2020. . https://doi.org/10.1101/2020.07.31.20165936 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2020. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 31, 2020. . https://doi.org/10.1101/2020.07.31.20165936 doi: medRxiv preprint CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 31, 2020. . https://doi.org/10.1101/2020.07.31.20165936 doi: medRxiv preprint Figure 2 -Seroconversion rates in study participants using different cut-off ratios 567 568 *One of the study participants with seroconversion between SP 2 and SP 3 had been tested 569 positive for SARS-CoV-2 by RT-PCR between SP 1 and SP 2, did therefore not attend the first 570 follow-up visit, and was thus counted as seroconverting between SP 2 and SP 3. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 31, 2020. . https://doi.org/10.1101/2020.07.31.20165936 doi: medRxiv preprint CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 31, 2020. . https://doi.org/10.1101/2020.07.31.20165936 doi: medRxiv preprint

COVID-19) Daily Situation Report of 484 the Robert Koch Institute

Implications of SARS-CoV-2 Infection 488 and COVID-19 Crisis on Clinical Cancer Care

Research electronic data capture (REDCap)--a 491 metadata-driven methodology and workflow process for providing translational 492 research informatics support

The REDCap consortium: Building an international 495 community of software platform partners

Clinical evaluation of five different automated 498

SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients

Validation of a commercially available SARS-CoV-2 501

Covid-19: Why Germany's case fatality rate seems so low

Hospital-Wide SARS-CoV-2 Antibody Screening in 506 3056 Staff in a Tertiary Center in Belgium

Dynamic of SARS-CoV-2 RT-PCR positivity and 508 seroprevalence among high-risk health care workers and hospital staff

SARS-CoV-2 among health care workers in a large Spanish reference hospital

Supplementary table -Symptoms reported by seropositive and -negative study participants 606

Total (n=1061) Seropositive (n=22) Seronegative (n=1041)

is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted July 31, 2020. virtual-press-conference---17-july.pdf?sfvrsn=dd7f91a1_0 [Accessed on 29 July 2020] 483 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2020. . https://doi.org/10.1101/2020.07.31.20165936 doi: medRxiv preprint 608 Respective symptoms as stated by the study participants at SP 1 or SP 2 for the preceding 609 month and at SP 3 for the preceding 2 months. Complete information was provided by a total 610 of 1061 participants. 611 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted July 31, 2020. . https://doi.org/10.1101/2020.07.31.20165936 doi: medRxiv preprint